The Department of Veterans Affairs (VA) National Acquisition Center awarded an Indefinite Delivery Contract (IDC) to Exelan Pharmaceuticals Inc. for the provision of Sildenafil Citrate tablets. This single-award contract, valued at up to $10,379,933.80, has an ordering period from October 27, 2022 to October 26, 2023 with four one-year option periods.
The contract aims to provide an uninterrupted supply of various strengths and package sizes of Sildenafil Citrate tablets to support the pharmaceutical needs of the VA, Department of Defense, Bureau of Prisons, and Indian Health Service through their respective Prime Vendor Programs. Exelan Pharmaceuticals, a foreign-owned for-profit pharmaceutical company, will serve as the prime contractor to fulfill orders placed against this IDC. The contract was awarded without any set-aside designations, allowing Exelan to compete against other unrestricted offerors. Funding for this procurement primarily originates from the VA National Acquisition Center.
Generated 9/26/24, 9:08 AM